IT1248743B - Metodo per la preparazione, in una forma non-racemica, di derivati della furo <3,4-c> piridina - Google Patents

Metodo per la preparazione, in una forma non-racemica, di derivati della furo <3,4-c> piridina

Info

Publication number
IT1248743B
IT1248743B ITMI911255A ITMI911255A IT1248743B IT 1248743 B IT1248743 B IT 1248743B IT MI911255 A ITMI911255 A IT MI911255A IT MI911255 A ITMI911255 A IT MI911255A IT 1248743 B IT1248743 B IT 1248743B
Authority
IT
Italy
Prior art keywords
derivatives
preparation
formula
fur
pyridin
Prior art date
Application number
ITMI911255A
Other languages
English (en)
Inventor
Charles R Eck
Paul C Ahrens
Rae Marie Saltzstein
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of ITMI911255A0 publication Critical patent/ITMI911255A0/it
Publication of ITMI911255A1 publication Critical patent/ITMI911255A1/it
Application granted granted Critical
Publication of IT1248743B publication Critical patent/IT1248743B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invenzione riguarda un metodo per la preparazione, in una forma sostanzialmente non-racemica di derivati della furo / 3,4-c / piridina aventi la formula (FORMULA I) e di loro sali farmaceuticamente accettabili, in cui R3, R'3, R4 e R6 rappresentono i versi sostituenti, detto metodo consistendo nel separare una miscela racemica di. uno dei composti aventi le formule (FORMULA II) in cui R3, R'3, R4, R6 sono come definiti sopra e R7 indica un gruppo acile avente fino a 18 atomi di carbonio, sottoponendo il composto scelto all'azione di un'esterasi capace di idrolizzare la forma enantiomerica (+) oppure la forma enantiomeríca (-) del composto scelto, quindi separare i composti non idrolizzati e i composti idrolizzati.
ITMI911255A 1990-05-14 1991-05-08 Metodo per la preparazione, in una forma non-racemica, di derivati della furo <3,4-c> piridina IT1248743B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/523,238 US5130252A (en) 1990-05-14 1990-05-14 Resolution of furopyridine enantiomers and synthetic precursors thereof

Publications (3)

Publication Number Publication Date
ITMI911255A0 ITMI911255A0 (it) 1991-05-08
ITMI911255A1 ITMI911255A1 (it) 1992-11-08
IT1248743B true IT1248743B (it) 1995-01-26

Family

ID=24084213

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911255A IT1248743B (it) 1990-05-14 1991-05-08 Metodo per la preparazione, in una forma non-racemica, di derivati della furo <3,4-c> piridina

Country Status (32)

Country Link
US (1) US5130252A (it)
JP (1) JPH05117277A (it)
KR (1) KR910020015A (it)
AR (1) AR247762A1 (it)
AT (1) AT400445B (it)
AU (1) AU642368B2 (it)
BE (1) BE1007016A3 (it)
CA (1) CA2042421C (it)
CH (1) CH682488A5 (it)
DE (1) DE4115681C2 (it)
DK (1) DK88991A (it)
DZ (1) DZ1499A1 (it)
ES (1) ES2033574B1 (it)
FI (1) FI97807C (it)
FR (1) FR2661919B1 (it)
GB (1) GB2244056B (it)
GR (1) GR1001593B (it)
HK (1) HK131993A (it)
IE (1) IE65891B1 (it)
IT (1) IT1248743B (it)
LU (1) LU87935A1 (it)
MA (1) MA22154A1 (it)
MY (1) MY107567A (it)
NL (1) NL194615C (it)
NO (1) NO180308C (it)
NZ (1) NZ238009A (it)
OA (1) OA09352A (it)
PT (1) PT97657B (it)
SE (1) SE510808C2 (it)
TN (1) TNSN91035A1 (it)
TW (1) TW226998B (it)
ZA (1) ZA913461B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221494D0 (en) * 2002-09-16 2002-10-23 Generics Uk Ltd Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives
WO2005009446A1 (en) * 2003-07-17 2005-02-03 Cotherix, Inc. Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
US20110251396A1 (en) * 2003-07-17 2011-10-13 Gilead Sciences, Inc. Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
WO2005021039A1 (en) * 2003-08-29 2005-03-10 Cotherix, Inc. Combination of cicletanine and an oral antidiabetic and/or blood lipid-lowering agent for treating diabetes and metabolic syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US7375112B2 (en) * 2005-01-05 2008-05-20 Medicure International Inc. Compounds and methods for regulating triglyceride levels
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
WO2008085872A1 (en) * 2007-01-03 2008-07-17 Cornett Glenn V Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders
WO2011053519A1 (en) * 2009-10-29 2011-05-05 Merck Sharp & Dohme Corp. Diuretics

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156817B (it) * 1981-02-10 1985-11-09 Scras
US4985365A (en) * 1981-11-28 1991-01-15 Sumitomo Chemical Company, Ltd. Process for producing optically active benzyl alcohol compound
EP0101076B1 (en) * 1982-08-13 1989-01-04 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for production of optically active oxazolidinone derivative
IN160104B (it) * 1983-04-05 1987-06-27 Scras
JPS59216590A (ja) * 1983-05-24 1984-12-06 Ube Ind Ltd 光学活性フエニルプロパルギルアルコ−ル誘導体の製法
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
JPS60224494A (ja) * 1984-04-24 1985-11-08 Nissan Chem Ind Ltd α−メチルベンジルアルコ−ル類の光学分割法
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
JPS61289899A (ja) * 1985-06-18 1986-12-19 Kanegafuchi Chem Ind Co Ltd 光学活性２−ハロ−１−フエニルエタノ−ルおよびそのエステルの製造法
US4916074A (en) * 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds
JP2691986B2 (ja) * 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
DE3737335A1 (de) * 1987-11-04 1989-05-18 Basf Ag Verfahren zur herstellung eines biokatalysators und dessen verwendung zur razematspaltung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
NL8801311A (nl) * 1988-05-20 1989-12-18 Stamicarbon Fenylglycidaatstereoisomeren, omzettingsprodukten daarvan met 2-nitrothiofenol en de bereiding van diltiazem.
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
PT97657A (pt) 1992-02-28
PT97657B (pt) 1998-09-30
GB2244056A (en) 1991-11-20
GR1001593B (el) 1993-03-31
AU7620091A (en) 1991-11-14
AU642368B2 (en) 1993-10-14
GR910100180A (en) 1992-07-30
KR910020015A (ko) 1991-12-19
FR2661919B1 (fr) 1994-12-30
ITMI911255A0 (it) 1991-05-08
GB9109810D0 (en) 1991-06-26
NL9100749A (nl) 1991-12-02
ZA913461B (en) 1992-02-26
IE911628A1 (en) 1991-11-20
NO911852D0 (no) 1991-05-13
CA2042421A1 (en) 1991-11-15
FI912315A (fi) 1991-11-15
ITMI911255A1 (it) 1992-11-08
NO911852L (no) 1991-11-15
CA2042421C (en) 2000-08-22
MA22154A1 (fr) 1991-12-31
HK131993A (en) 1993-12-10
NL194615B (nl) 2002-05-01
BE1007016A3 (fr) 1995-02-21
CH682488A5 (fr) 1993-09-30
FI912315A0 (fi) 1991-05-13
OA09352A (fr) 1992-09-15
NZ238009A (en) 1992-11-25
FI97807C (fi) 1997-02-25
GB2244056B (en) 1993-08-11
FI97807B (fi) 1996-11-15
SE510808C2 (sv) 1999-06-28
AR247762A1 (es) 1995-03-31
AT400445B (de) 1995-12-27
DE4115681A1 (de) 1991-11-21
US5130252A (en) 1992-07-14
ATA98291A (de) 1995-05-15
JPH05117277A (ja) 1993-05-14
SE9101431D0 (sv) 1991-05-13
DK88991D0 (da) 1991-05-13
DE4115681C2 (de) 2003-10-30
FR2661919A1 (fr) 1991-11-15
NO180308C (no) 1997-03-26
DK88991A (da) 1991-11-15
MY107567A (en) 1996-04-30
NL194615C (nl) 2002-09-03
ES2033574A1 (es) 1993-03-16
SE9101431L (sv) 1991-11-15
TNSN91035A1 (fr) 1992-10-25
TW226998B (it) 1994-07-21
IE65891B1 (en) 1995-11-29
ES2033574B1 (es) 1994-02-01
DZ1499A1 (fr) 2004-09-13
NO180308B (no) 1996-12-16
LU87935A1 (fr) 1992-03-03

Similar Documents

Publication Publication Date Title
PT77018A (fr) Procede de preparation de nouveaux derives de la thieno (3,2-c) pyridine et de compositions pharmaceutiques les contenant
IT1248743B (it) Metodo per la preparazione, in una forma non-racemica, di derivati della furo &lt;3,4-c&gt; piridina
HU906402D0 (en) Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance
PT79819B (en) Process to prepare dihydropiridazinone derivatives its salts and pharmaceutical compositions and intermediate compounds there with
NO301542B1 (no) Nye pyrazin-derivater
FR2649110B1 (fr) Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE8404555D0 (sv) Mellanprodukter for framstellning av 2-substituerade trans-5-aryl-2,3,4,4a,9b-hexahydro-1h-pyrido(4,3-b)indoler
CH637658A5 (it) Analoghi degli alcaloidi dell&#39;ergot.
FR2595701B1 (fr) Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
AU567117B2 (en) Indene derivatives
DE3574471D1 (de) 1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
KR940005638A (ko) 티에노티아진 유도체, 이의 제조방법 및 용도
PT96757A (pt) Processo de preparacao de derivados de indolo e de composicoes farmaceuticas
ATE8996T1 (de) Benzo(4,5)pyrano(2,3-c)pyrrole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3782548D1 (de) Ergolin-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FR2626279B1 (fr) Nouveaux derives de l&#39;indolo(3,2,1-de)(1,4)-oxazino(2,3,4-ij)(1,5) naphthyridine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
DE3873786D1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4-b)indol-1-essigsaeuren.
FR2523964B1 (fr) Nouveaux derives de la tryptamine actifs notamment sur le systeme cardiovasculaire et procede pour leur preparation
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
SE7612319L (sv) Forfarande for framstellning av bensomorfanderivat.
IE42992L (en) PYRIMIDO [1,2-a] QUINOLINE DERIVATIVES
DE69533833D1 (de) Verfahren zur Herstellung von Indolopyrrolocarbazol-Derivaten
CH638814A5 (fr) 4-desacetoxy-4alpha-hydroxyindole-dihydroindols et leur preparation.
JPS5236696A (en) Process for preparation of hexahydro-1h- pyrido(4,3-b)-indoles
SE8405332D0 (sv) 2h-azeto(2,1-a)-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970529